15 maggio 1. ADDRESSING THE UNEXPECTED: PI-RADS 4 AND 5 AND NEGATIVE PROSTATE BIOPSY RESULTS 2. ASSESSING EFFECTIVENESS OF ‘ONABOTULINUMTOXIN A’ (BOTOX®) INTRADETRUSOR INJECTION FOR OVERACTIVE BLADDER (OAB) PATIENTS AFTER MEDICAL THERAPY FAILURE 3. ASSESSING EFFECTIVENESS OF ‘ONABOTULINUMTOXIN A’ (BOTOX®) INTRADETRUSOR INJECTION FOR OVERACTIVE BLADDER PATIENTS AFTER ENDOSCOPIC INTERVENTIONS FOR BENIGN PROSTATIC HYPERPLASIA (BPH) 4. BIPOLAR PLASMA TURP FOR PROSTATE BETWEEN 125 TO 200 ML OF VOLUME 5. IMPROVEMENT OF QUALITY OF LIFE FROM PERMANENT CATHETER TO SELF INTERMITTENT CATHETER IN BPH 6. ENUCLEAZIONE ENDOSCOPICA DELLA PROSTATA CON LASER TULLIO (THULEP) VERSUS ADENOMECTOMIA PROSTATICA LAPAROSCOPICA PER IL TRATTAMENTO DELLA IPERTROFIA PROSTATICA DI ALTO VOLUME, STUDIO MONOCENTRICO 7. THULIUM VAPO RESECTION OF PROSTATE (THUVARP) AS A VALID THERAPEUTIC OPTION IN BENIGN PROSTATE OBSTRUCTION (BPO) 8. PROSPECTIVE OBSERVATIONAL STUDY ON THE EFFICACY AND TOLERABILITY OF A COMPLEX OF PHYTOCHEMICALS VERSUS DUTASTERIDE IN THE TREATMENT OF LOWER URINARY TRACT SYMPTOMPS DUE TO BENIGN PROSTATIC HYPERPLASIA